Both in Biotechnology
Adaptive Biotechnologies vs Immunovant
Over the past year ADPT returned +44.5% and IMVT returned +19.5%; their daily moves had a correlation of 0.23.
ADPT +44.5% IMVT +19.5%Growth of $1, one year, split-adjusted
| Metric | ADPT | IMVT |
|---|---|---|
| Price | $25.06 | $28.41 |
| Market cap | $4.00B | $5.87B |
| Today | −5.93% | −2.61% |
| 1 month | −11.6% | −15.5% |
| 6 months | +72.8% | +2.0% |
| Year to date | +54.3% | +11.8% |
| 1 year | +48.2% | +14.5% |
| Revenue growth (YoY) | +21.5% | — |
| Gross margin | 71.8% | — |
| Net margin | −55.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.0× | — |
| Net cash | $9.4M | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 37.0% |
| Short % of float | 10.0% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).